Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · IEX Real-Time Price · USD
2.000
+0.200 (11.11%)
At close: May 17, 2024, 4:00 PM
2.010
+0.010 (0.50%)
After-hours: May 17, 2024, 7:52 PM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $150.00 million as of May 17, 2024. Its market cap has increased by 1,512.87% in one year.
Market Cap
150.00M
Enterprise Value
139.91M
1-Year Change
1,512.87%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $150.00M, an increase of 193.95%. That is a compound annual growth rate of 51.99%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 150.00M | 11.11% |
May 16, 2024 | 135.00M | 6.55% |
May 15, 2024 | 126.70M | -1.17% |
May 14, 2024 | 128.20M | 1.75% |
May 13, 2024 | 126.00M | -10.13% |
May 10, 2024 | 140.20M | 2.19% |
May 9, 2024 | 137.20M | 1.11% |
May 8, 2024 | 135.70M | 393.45% |
May 7, 2024 | 27.50M | -3.17% |
May 6, 2024 | 28.40M | -3.73% |
May 3, 2024 | 29.50M | 5.73% |
May 2, 2024 | 27.90M | 28.57% |
May 1, 2024 | 21.70M | 0.93% |
Apr 30, 2024 | 21.50M | -1.83% |
Apr 29, 2024 | 21.90M | -2.67% |
Apr 26, 2024 | 22.50M | 2.27% |
Apr 25, 2024 | 22.00M | 5.77% |
Apr 24, 2024 | 20.80M | -7.56% |
Apr 23, 2024 | 22.50M | 3.69% |
Apr 22, 2024 | 21.70M | 2.84% |
Apr 19, 2024 | 21.10M | -6.22% |
Apr 18, 2024 | 22.50M | 1.35% |
Apr 17, 2024 | 22.20M | -4.72% |
Apr 16, 2024 | 23.30M | -2.51% |
Apr 15, 2024 | 23.90M | 0.42% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ProQR Therapeutics | 156.58M |
X4 Pharmaceuticals | 156.18M |
Repare Therapeutics | 152.80M |
Cardiol Therapeutics | 152.58M |
CytomX Therapeutics | 151.16M |
Harvard Bioscience | 148.31M |
American Well | 147.46M |
Sagimet Biosciences | 147.18M |